Form 8-K - Current report:
SEC Accession No. 0001096906-17-000615
Filing Date
2017-09-25
Accepted
2017-09-22 21:48:53
Documents
2
Period of Report
2017-09-25
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8K aoxing.htm 8-K 13273
2 PRESS RELEASE DATED SEPTEMBER 25, 2017 exh99_1.htm EX-99.1 6341
  Complete submission text file 0001096906-17-000615.txt   21167
Mailing Address 1098 FOSTER CITY BLVD. SUITE 106-810 FOSTER CITY CA 94404
Business Address 1098 FOSTER CITY BLVD. SUITE 106-810 FOSTER CITY CA 94404 646-367-1747
AOXING PHARMACEUTICAL COMPANY, INC. (Filer) CIK: 0001060426 (see all company filings)

EIN.: 650636168 | State of Incorp.: FL | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-32674 | Film No.: 171098516
SIC: 2834 Pharmaceutical Preparations